This site is intended for healthcare professionals
3d rendered medically accurate illustration of a womans large intestine
Ulcerative colitis Learning Zone
Declaration of sponsorship Bristol Myers Squibb

Treatment decision-making for ulcerative colitis

Declaration of sponsorship Bristol Myers Squibb
Read time: 30 mins
Last updated:22nd Sep 2023
Published:22nd Sep 2023

Treatment decision-making for ulcerative colitis

What is timely treatment progression in ulcerative colitis (UC), and why is it an important consideration for clinicians managing UC? Learn more about the value of prompt treatment escalation and explore the risks associated with steroid complacency.

Expert-led assessment of relevant clinical guidance

Free scientific information and eLearning for healthcare professionals only

Including CME accreditation, podcasts, webinars and over 50 Learning Zones

Medthority is ad free, so you can learn without distraction

With an increasing number of available medications for the management of ulcerative colitis (UC), treatment decision-making has become increasingly complex10. To optimise UC management, explore factors that influence treatment selection, sequencing and switching, and indications for surgery.

Expert-led assessment of relevant clinical guidance

Free scientific information and eLearning for healthcare professionals only

Including CME accreditation, podcasts, webinars and over 50 Learning Zones

Medthority is ad free, so you can learn without distraction

Explore how optimal shared decision-making can improve treatment outcomes for people with UC, and the importance of coordinated care across multidisciplinary teams.

743_Ulcerative Colitis_T3_Fig4_LO4.png

Expert-led assessment of relevant clinical guidance

Free scientific information and eLearning for healthcare professionals only

Including CME accreditation, podcasts, webinars and over 50 Learning Zones

Medthority is ad free, so you can learn without distraction

Welcome: